Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1

Authors

Andrew J Lutkewitte, Washington University School of Medicine in St. Louis
Jason M Singer, Washington University School of Medicine in St. Louis
Trevor M Shew, Washington University School of Medicine in St. Louis
Michael R Martino, Washington University School of Medicine in St. Louis
Angela M Hall, Washington University School of Medicine in St. Louis
Mai He, Washington University School of Medicine in St. Louis
Brian N Finck, Washington University School of Medicine in St. Louis

Journal

Molecular Metabolism

Publication Date

7-1-2021

Volume

49

First Page

101204

Document Type

Open Access Publication

DOI

10.1016/j.molmet.2021.101204

Rights and Permissions

Lutkewitte AJ, Singer JM, Shew TM, Martino MR, Hall AM, He M, Finck BN. Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1. Mol Metab. 2021 Jul;49:101204. doi: 10.1016/j.molmet.2021.101204. Copyright 2021 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). www.molecularmetabolism.com

Recommended Citation

Lutkewitte, Andrew J; Singer, Jason M; Shew, Trevor M; Martino, Michael R; Hall, Angela M; He, Mai; and Finck, Brian N, "Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1." Molecular Metabolism. 49, 101204 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10763